^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Salivary Gland Cancer |
| Drug: | cisplatin (DNA synthesis inhibitor) + doxorubicin hydrochloride (Topoisomerase II inhibitor) + cyclophosphamide (Alkylating agent) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Preferred regimens (first-line) for recurrent, unresectable or metastatic non-nasopharyngeal cancer…Included cisplatin/doxorubicin/cyclophosphamide (category 2 B) and cisplatin/vinorelbine as other recommended chemotherapy options for salivary gland tumors.
